{
    "clinical_study": {
        "@rank": "166483", 
        "arm_group": {
            "arm_group_label": "renal mass ablation candidates", 
            "description": "Standard of care interventions for the treatment of renal masses using energy ablation will be studied. Data collection can be divided into five basic categories: 1) Patient demographics and relevant history, 2) Renal mass characteristics, 3) Ablation procedure details, 4) Imaging studies, and 5) Patient-reported quality of life."
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to better understand how effective ablation is for destroying\n      tumor cells in the kidney and whether quality of life is improved for patients.\n      Participation in ARMOR may involve retrospective data collection only, combined\n      retrospective and prospective data collection, or prospective data collection"
        }, 
        "brief_title": "Ablation of Renal Masses Outcomes Registry (ARMOR): Ablation Procedure and Quality of Life Assessment", 
        "completion_date": {
            "#text": "June 2018", 
            "@type": "Anticipated"
        }, 
        "condition": "Renal Cancer", 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma, Renal Cell", 
                "Kidney Neoplasms"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Retrospective enrollment:\n\n        - Patients having undergone percutaneous, open or laparoscopic energy ablation of a renal\n        mass.\n\n        Prospective enrollment:\n\n        - Patients scheduled to undergo, rather than having undergone, percutaneous, open or\n        laparoscopic energy ablation of a renal mass.\n\n        Exclusion Criteria:\n\n          -  Patients not having undergone, or considered candidates for percutaneous, open or\n             laparoscopic energy ablation of a renal mass\n\n          -  Non-English speaking patients\n\n          -  Patients under the age of 18."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "The patients at MSKCC will be identified and recruited from the existing patient\n        population in the Interventional Radiology Service in the Department of Radiology. At all\n        other participating sites, patients meeting eligibility criteria will be identified by the\n        site investigators that have received the referral for consideration of renal mass\n        ablation. Participation in ARMOR may involve retrospective data collection only, combined\n        retrospective and prospective data collection, or prospective data collection"
            }
        }, 
        "enrollment": {
            "#text": "600", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 24, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01888198", 
            "org_study_id": "MSKCC 13-116"
        }, 
        "intervention": [
            {
                "arm_group_label": "renal mass ablation candidates", 
                "intervention_name": "(EORTC QLQ-C30) questionnaire", 
                "intervention_type": "Behavioral", 
                "other_name": "European Organization for Research and Treatment of Cancer 30-item"
            }, 
            {
                "arm_group_label": "renal mass ablation candidates", 
                "intervention_name": "EuroQol EQ-5D 7-item questionnaire", 
                "intervention_type": "Behavioral"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "ablation", 
            "quality of Life (QOL)", 
            "kidney", 
            "registry", 
            "Ablation of Renal Masses Outcomes Registry (ARMOR)", 
            "13-116"
        ], 
        "lastchanged_date": "May 21, 2014", 
        "link": {
            "description": "Memorial Sloan-Kettering Cancer Center", 
            "url": "http://www.mskcc.org/"
        }, 
        "location": [
            {
                "contact": {
                    "last_name": "Richard Howard, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Baltimore", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "21201"
                    }, 
                    "name": "University of Maryland Medical Center"
                }, 
                "investigator": {
                    "last_name": "Richard Howard, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Jeremy Durack, MD", 
                    "phone": "212-639-4898"
                }, 
                "contact_backup": {
                    "last_name": "Stephen Solomon, MD", 
                    "phone": "212-639-5012"
                }, 
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10065"
                    }, 
                    "name": "Memorial Sloan-Kettering Cancer Center"
                }, 
                "investigator": {
                    "last_name": "Jeremy Durack, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Colette Shaw, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Philadelphia,", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19107"
                    }, 
                    "name": "Thomas Jefferson University Hospital"
                }, 
                "investigator": {
                    "last_name": "Colette Shaw, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Damian Dupuy, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Providence", 
                        "country": "United States", 
                        "state": "Rhode Island", 
                        "zip": "02903"
                    }, 
                    "name": "Rhode Island Hospital"
                }, 
                "investigator": {
                    "last_name": "Damian Dupuy, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Ablation of Renal Masses Outcomes Registry (ARMOR): Ablation Procedure and Quality of Life Assessment", 
        "overall_contact": {
            "last_name": "Jeremy Durack, MD", 
            "phone": "212-639-4898"
        }, 
        "overall_contact_backup": {
            "last_name": "Stephen Solomon, MD", 
            "phone": "212-639-5012"
        }, 
        "overall_official": {
            "affiliation": "Memorial Sloan-Kettering Cancer Center", 
            "last_name": "Jeremy Durack, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To assess renal ablation outcomes using standard quality of life measures. Specifically, quality of life outcomes measures will be analyzed with respect to ablation procedure characteristics including ablation technique and anesthesia type as well as renal mass characteristics such as size, location and pathologic tumor type.", 
            "measure": "assess renal ablation outcomes", 
            "safety_issue": "No", 
            "time_frame": "5 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01888198"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "between CT and MR related to renal ablation. We hypothesize that, after ablation, the observed relative change in contrast enhancement at the site of ablation for each follow-up time point will be similar for tumors imaged by CT compared with those imaged by MR. This objective will be met by observational and descriptive methods.", 
                "measure": "differences in imaging characteristics", 
                "safety_issue": "No", 
                "time_frame": "5 years"
            }, 
            {
                "description": "in terms of size and contrast enhancement at the site of renal ablation, correlated with ablation technology and tumor histopathology. The objective is to determine whether the choice of imaging method, ablation technique, or histopathologic tumor subtype will be associated with similar relative change in contrast enhancement and size after ablation.", 
                "measure": "Assess the progression of imaging findings", 
                "safety_issue": "No", 
                "time_frame": "5 years"
            }, 
            {
                "description": "associated with CT imaging performed during an ablation procedure and subsequent imaging follow-up to 2 years. Radiation dose will be analyzed using multivariable linear regression, with ablation technique as the primary predictor.", 
                "measure": "Radiation exposure", 
                "safety_issue": "Yes", 
                "time_frame": "5 years"
            }
        ], 
        "source": "Memorial Sloan-Kettering Cancer Center", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "KAISER SAN RAPHAEL", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Johns Hopkins University", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Rhode Island Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "M.D. Anderson Cancer Center", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Massachusetts General Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of California, San Francisco", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Thomas Jefferson University", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of Tennessee Medical Center, Knoxville", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of North Carolina, Chapel Hill", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Vancouver General Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Barbara Ann Karmanos Cancer Institute", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Lahey Clinic", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Mount Sinai School of Medicine", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of Maryland, Baltimore County", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Baylor College of Medicine", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Dartmouth-Hitchcock Medical Center", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of Wisconsin, Madison", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "San Diego Imaging Medical Group", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Memorial Sloan-Kettering Cancer Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Observational Model: Cohort", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "24 Months", 
        "verification_date": "May 2014"
    }
}